Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | Combo: DNA & vector vaccines |
| Study Type: | Phase II |
| Species: | Human |
| Stage: | Primary Analysis Complete |
| Study Start Date: | 2009-05-29 |
| Study Made Public: | NA |
Title
Phase 2b, randomized, placebo-controlled test-of- concept trial to evaluate the safety and efficacy of a multiclade HIV-1 DNA plasmid vaccine followed by a multiclade HIV-1 recombinant adenoviral vector vaccine in HIV-uninfected, adenovirus type 5 neutralizing antibody negative, circumcised men and male-to-female (MTF) transgender persons, who have sex with men
Description
HVTN 505 is a Phase IIb clinical trial to evaluate the safety and immunogenicity of VRC-HIVDNA016-00-VP (DNA) and VRCHIVADV014-00-VP (rAd5).
Sign in to see full information about this study and to download study data.
Products
VRC-HIVDNA016-00-VP VRC-HIVADV014-00-VP VRC-PBSPLA043-00-VP VRC-DILUENT013-DIL VPIntegrated data
BAMA, ICS, NAb
Non-integrated data
ADCP, Demographics (Supplemental), Fc Array